Conversely, glioblastoma-derived factors, like TGF β, IL-10, prostaglandin E2, can lock DCs in a tolerogenic state characterized by PD-L1 expression and diminished IL-12 production, thereby dampening T cell activation (27). The gene discussed is IL10; the disease is glioblastoma.